Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms.

Authors:
Address: Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada T6G 2N8.
Journal:

Publication:

abstract

Dioxins are known to cause several human cancers through activation of the aryl hydrocarbon receptor (AhR). Harmaline and harmalol are dihydro-β-carboline compounds present in several medicinal plants such as Peganum harmala. We have previously demonstrated the ability of P. harmala extract to inhibit TCDD-mediated induction of CYP1A1 in murine hepatoma Hepa 1c1c7 cells. Therefore, the aim of this study is to examine the effect of harmaline and its main metabolite, harmalol, on dioxin-mediated induction of CYP1A1 in human hepatoma HepG2 cells. Our results showed that harmaline and harmalol at concentrations of (0.5-12.5μM) significantly inhibited the dioxin-induced CYP1A1 at mRNA, protein and activity levels in a concentration-dependent manner. The role of AhR was determined by the inhibition of the TCDD-mediated induction of AhR-dependent luciferase activity and the AhR/ARNT/XRE formation by both harmaline and harmalol. In addition, harmaline significantly displaced [(3)H]TCDD in the competitive ligand binding assay. At posttranslational level, both harmaline and harmalol decreased the protein stability of CYP1A1, suggesting that posttranslational modifications are involved. Moreover, the posttranslational modifications of harmaline and harmalol involve ubiquitin-proteasomal pathway and direct inhibitory effects of both compounds on CYP1A1 enzyme. These data suggest that harmaline and harmalol are promising agents for preventing dioxin-mediated effects.

Related Articles
Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol.
Toxicol Lett. 2012
Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol.
El Gendy MA, Soshilov AA, Denison MS, El-Kadi AO. Toxicol Lett. 2012 Jan 5; 208(1):51-61. Epub 2011 Oct 6.
Peganum harmala L. is a candidate herbal plant for preventing dioxin mediated effects.
Planta Med. 2010
Peganum harmala L. is a candidate herbal plant for preventing dioxin mediated effects.
El Gendy MA, Somayaji V, El-Kadi AO. Planta Med. 2010 May; 76(7):671-7. Epub 2009 Nov 25.
Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase.
Toxicology. 2012
Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase.
Korashy HM, El-Kadi AO. Toxicology. 2012 Jan 27; 291(1-3):113-21. Epub 2011 Nov 22.
Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells.
J Biol Chem. 1997
Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells.
Backlund M, Johansson I, Mkrtchian S, Ingelman-Sundberg M. J Biol Chem. 1997 Dec 12; 272(50):31755-63.
Down-regulation of the carcinogen-metabolizing enzyme cytochrome P450 1a1 by vanadium.
Drug Metab Dispos. 2008
Down-regulation of the carcinogen-metabolizing enzyme cytochrome P450 1a1 by vanadium.
Anwar-Mohamed A, El-Kadi AO. Drug Metab Dispos. 2008 Sep; 36(9):1819-27. Epub 2008 Jun 9.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.